Mocroft, A

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 12.

Journal Article

Béguelin, C; Atkinson, A; Boyd, A; Falconer, K; Kirkby, N; Suter-Riniker, F; Günthard, H F; Rockstroh, J K; Mocroft, A; Rauch, A; Peters, L; Wandeler, G (2023). Hepatitis delta infection among persons living with HIV in Europe. Liver international, 43(4), pp. 819-828. Wiley 10.1111/liv.15519

Atkinson, Andrew; Zwahlen, Marcel; Barger, D; d'Arminio Monforte, A; De Wit, S; Ghosn, J; Girardi, E; Svedhem-Johansson, V; Morlat, P; Mussini, C; Noguera-Julian, A; Stephan, C; Touloumi, G; Kirk, O; Mocroft, A; Reiss, P; Miro, J M; Carpenter, J R; Furrer, Hansjakob (2021). Withholding primary PcP prophylaxis in virologically suppressed HIV patients: An emulation of a pragmatic trial in COHERE. Clinical infectious diseases, 73(2), pp. 195-202. The University of Chicago Press 10.1093/cid/ciaa615

Mocroft, A (2020). Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment. HIV medicine, 21(9), pp. 599-606. Wiley 10.1111/hiv.12888

Roen, A O; Podlekareva, D; Miller, R F; Mocroft, A; Panteleev, A; Skrahina, A; Miro, J M; Cayla, J A; Tetradov, S; Derisova, E; Furrer, H; Losso, M H; Vassilenko, A; Girardi, E; Lundgren, J D; Post, F A; Kirk, O (2020). A new health care index predicts short term mortality for TB and HIV co-infected people. The international journal of tuberculosis and lung disease, 24(9), pp. 956-962. IUATLD 10.5588/ijtld.19.0568

Laut, K; Kirk, O; Rockstroh, J; Phillips, A; Ledergerber, B; Gatell, J; Gazzard, B; Horban, A; Karpov, I; Losso, M; d'Arminio Monforte, A; Pedersen, C; Ristola, M; Reiss, P; Scherrer, A U; de Wit, S; Aho, I; Rasmussen, L D; Svedhem, V; Wandeler, Gilles; ... (2020). The EuroSIDA study: 25 years of scientific achievements. HIV medicine, 21(2), pp. 71-83. Blackwell Science 10.1111/hiv.12810

Amele, S; Peters, L; Sluzhynska, M; Yakovlev, A; Scherrer, A; Domingo, P; Gerstoft, J; Viard, J P; Gisinger, M; Flisiak, R; Bhaghani, S; Ristola, M; Leen, C; Jablonowska, E; Wandeler, Gilles; Stellbrink, H; Falconer, K; D'Arminio Monforte, A; Horban, A; Rockstroh, J K; ... (2019). Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA. HIV medicine, 20(4), pp. 264-273. Blackwell Science 10.1111/hiv.12711

Efsen, A M W; Schultze, A; Miller, R F; Panteleev, A; Skrahin, A; Podlekareva, D N; Miro, J M; Girardi, E; Furrer, Hansjakob; Losso, M H; Toibaro, J; Caylà, J A; Mocroft, A; Lundgren, J D; Post, F A; Kirk, O (2018). Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study. Journal of infection, 76(1), pp. 44-54. Elsevier 10.1016/j.jinf.2017.10.007

Podlekareva, D.N.; Schultze, A; Panteleev, A; Skrahina, A.M.; Miro, J.M.; Furrer, Hansjakob; Rakhmanova, A; Miller, R.F.; Efsen, A.M.W.; Losso, M.H.; Toibaro, J; Vassilenko, A; Girardi, E; Lundgren, J.D.; Mocroft, A; Kirk, O (2017). One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America. AIDS, 31(3), pp. 375-384. Lippincott Williams & Wilkins 10.1097/QAD.0000000000001333

Mansfeld, M; Skrahina, A; Shepherd, L; Schultze, A; Panteleev, A M; Miller, R F; Miro, J M; Zeltina, I; Tetradov, S; Furrer, Hansjakob; Kirk, O; Grzeszczuk, A; Bolokadze, N; Matteelli, A; Post, F A; Lundgren, J D; Mocroft, A; Efsen, Amw; Pdlekareva, D N (2015). Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe. HIV medicine, 16(9), pp. 544-552. Blackwell Science 10.1111/hiv.12256

Achhra, Ac; Mocroft, A; Ross, Mj; Ryom, L; Lucas, Gm; Furrer, Hansjakob; Neuhaus, J; Somboonwit, C; Kelly, M; Gatell, Jm; Wyatt, Cm (2015). Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV medicine, 16(Suppl1), pp. 55-63. Blackwell Science 10.1111/hiv.12234

Bohlius, Julia; Bohlius, J; Schmidlin, K; Costagliola, D; Fätkenheuer, G; May, M; Caro-Murillo, AM; Mocroft, A; Bonnet, F; Clifford, G; Karafoulidou, A; Miro, JM; Lundgren, J; Chene, G; Egger, Matthias (2009). Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antiviral therapy, 14(8), pp. 1065-74. London: International Medical Press 10.3851/IMP1462

Antiretroviral, Therapy in Low-Income Countries Collaboration of the Internation; Cohort Collaboration, ART; Brinkhof, MW; Egger, M; Boulle, A; May, M; Hosseinipour, M; Sprinz, E; Braitstein, P; Dabis, F; Reiss, P; Bangsberg, DR; Rickenbach, M; Miro, JM; Myer, L; Mocroft, A; Nash, D; Keiser, O; Pascoe, M; van der Borght, S; ... (2007). Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. Clinical infectious diseases, 45(11), pp. 1518-21. Cary, N.C.: Oxford University Press 10.1086/522986

This list was generated on Fri Mar 29 16:00:17 2024 CET.
Provide Feedback